Skip to main content
Log in

High prevalence of peripheral arterial disease in patients with obstructive sleep apnoea

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Introduction

Obstructive sleep apnoea (OSA) merits increasing attention as cardiovascular risk factor. Whereas carotid and coronary artery disease have been associated with OSA, occurrence of peripheral arterial disease (PAD) in OSA remains undefined.

Methods

We screened 100 patients with suspected OSA for PAD. After polysomnography, each patient underwent standardized angiological testing including ankle-brachial index (ABI), central pulse wave velocity, pulse wave index and duplex sonography.

Results

Among total study population, PAD prevalence accounted for 88 %, of those 68 % had asymptomatic plaques and 20 % were symptomatic Fontaine ≥IIa. In confirmed OSA, prevalence raised up to 98 %. Except for smoking habits, distribution of established risk factors did not differ between OSA groups (patients without, mild, intermediate and severe OSA). Presence of plaque, Fontaine PAD stages and intermittent claudication exhibited significant gain with increasing AHI. A logistic regression model revealed that age (OR = 1.199, 95 % CI [1.066; 1.348]) and the logarithmically transformed AHI (OR = 5.426, 95 % CI [1.068; 27.567]) had the strongest influence on plaque presence. Central pulse wave velocity as marker of arterial stiffness was positively correlated with AHI.

Conclusion

OSA is associated with a high prevalence of PAD. This implies substantial disease´s under-recognition and a presumable atherogenic role of OSA in the pathogenesis of PAD. However, vasoprotective impact of OSA treatment remains to be determined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Punjabi NM (2008) The epidemiology of adult obstructive sleep apnoea. Proc Am Thorac Soc 5:136–143

    Article  PubMed Central  PubMed  Google Scholar 

  2. Narkiewicz K, Somers VK (2003) Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand 177:385–390

    Article  CAS  PubMed  Google Scholar 

  3. Okcay A, Somers VK, Caples SM (2008) Obstructive sleep apnoea and hypertension. J Clin Hypertens (Greenwich) 10:549–555

    Article  Google Scholar 

  4. Narkiewicz K, Wolf J, Lopez-Jimenez F, Somers VK (2005) Obstructive sleep apnoea and hypertension. Curr Cardiol Rep 7:435–440

    Article  PubMed  Google Scholar 

  5. Jelic S, Padeletti M, Kawut SM et al (2008) Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnoea. Circulation 117:2270–2278

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Davignon J, Ganz P (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 109:III27–32

  7. Shamsuzzaman AS, Winnicki M, Lanfranchi P et al (2002) Elevated C-reactive protein in patients with obstructive sleep apnoea. Circulation 105:2462–2464

    Article  CAS  PubMed  Google Scholar 

  8. Svatikova A, Wolk R, Shamsuzzaman AS, Kara T, Olson EJ, Somers VK (2003) Serum amyloid a in obstructive sleep apnoea. Circulation 108:1451–1454

    Article  CAS  PubMed  Google Scholar 

  9. Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T, Ouchi Y (2003) Effects of obstructive sleep apnoea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94:179–184

    Article  CAS  PubMed  Google Scholar 

  10. Knutson KL, Van Cauter E (2008) Associations between sleep loss and increased risk of obesity and diabetes. Ann N Y Acad Sci 1129:287–304

    Article  PubMed Central  PubMed  Google Scholar 

  11. Calvin AD, Albuquerque FN, Lopez-Jimenez F, Somers VK (2009) Obstructive sleep apnoea, inflammation, and the metabolic syndrome. Metab Syndr Relat Disord 7:271–278

    Article  PubMed Central  PubMed  Google Scholar 

  12. Tuleta I, Pabst S, Juergens UR, Nickenig G, Skowasch D (2011) Obstructive sleep apnoea as a risk factor for atherosclerosis—implication for preventive and personalised treatment. EPMA J 2:39–47

    Article  PubMed  Google Scholar 

  13. Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U (2001) Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med 164:1910–1913

    Article  CAS  PubMed  Google Scholar 

  14. Schafer H, Koehler U, Ewig S, Hasper E, Tasci S, Luderitz B (1999) Obstructive sleep apnoea as a risk marker in coronary artery disease. Cardiology 92:79–84

    Article  CAS  PubMed  Google Scholar 

  15. Somers VK, White DP, Amin R et al (2008) Sleep apnoea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 118:1080–1111

    Article  PubMed  Google Scholar 

  16. Arias MA, Garcia-Rio F, Alonso-Fernandez A, Mediano O, Martinez I, Villamor J (2005) Obstructive sleep apnoea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 112:375–383

    Article  PubMed  Google Scholar 

  17. Altekin RE, Yanikoglu A, Karakas MS et al (2012) Assessment of left atrial dysfunction in obstructive sleep apnea patients with the two dimensional speckle-tracking echocardiography. Clin Res Cardiol 101:403–413

    Article  PubMed  Google Scholar 

  18. Dimitradis Z, Wiemer M, Scholtz W et al (2013) Sleep-disordered breathing in patients undergoing transfemoral aortic valve implantation for severe aortic stenosis. Clin Res Cardiol 102:895–903

    Article  Google Scholar 

  19. Nakamura S, Asai K, Kubota Y et al (2014) Impact of sleep-disordered breathing and efficacy of positive airway pressure on mortality in patients with chronic heart failure and sleep disordered breathing: a meta-analysis. Clin Res Cardiol 103:805–815

    Article  Google Scholar 

  20. Utriainen KT, Airaksinen JK, Polo O et al (2014) Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease. Eur Respir J 41:616–620

    Article  Google Scholar 

  21. Hammerstingl C, Schueler R, Wiesen M et al (2012) Effects of untreated obstructive sleep apnoea on left and right ventricular myocardial function. Int J Cardiol 155:465–469

    Article  PubMed  Google Scholar 

  22. Hammerstingl C, Schueler R, Wiesen M et al (2013) Impact of untreated obstructive sleep apnoea on left- and right ventricular myocardial function and effects of CPAP therapy. PLoS One 8:e76352

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Hein H, Raschke F, Kohler D, Mayer G, Peter JH, Ruhle KH (2001) Guideline on diagnostics and treatment of sleep-related respiratory disorders in adults. Pneumologie 55:339–342

    Article  CAS  PubMed  Google Scholar 

  24. Epstein LJ, Kristo D, Strollo PJ Jr et al (2009) Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnoea in adults. J Clin Sleep Med 5:263–276

    PubMed  Google Scholar 

  25. Berry RB, Budhiraja R, Gottlieb DJ et al (2012) Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 8:597–619

    PubMed Central  PubMed  Google Scholar 

  26. Tendera M, Aboyans V, Bartelink ML et al (2011) ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 32:2851–2906

    Article  PubMed  Google Scholar 

  27. Katakam R, Townsend RR (2006) What’s in a pulse? J Clin Hypertens (Greenwich) 8:140–141

    Article  Google Scholar 

  28. Criqui MH (2001) Peripheral arterial disease-epidemiological aspects. Vasc Med 6:3–7

    Article  CAS  PubMed  Google Scholar 

  29. Diehm C, Schuster A, Allenberg JR et al (2004) High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 172:95–105

    Article  CAS  PubMed  Google Scholar 

  30. Utriainen KT, Airaksinen JK, Polo O et al (2014) Sleep apnoea is associated with major cardiac events in peripheral arterial disease. Eur Respir J 43:1652–1660

    Article  PubMed  Google Scholar 

  31. Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, Somers VK (1999) Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 17:61–66

    Article  CAS  PubMed  Google Scholar 

  32. Kraiczi H, Caidahl K, Samuelsson A, Peker Y, Hedner J (2001) Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest 119:1085–1091

    Article  CAS  PubMed  Google Scholar 

  33. Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897–1904

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  34. Dyugovskaya L, Lavie P, Lavie L (2002) Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165:934–939

    Article  PubMed  Google Scholar 

  35. El Solh AA, Akinnusi ME, Baddoura FH, Mankowski CR (2007) Endothelial cell apoptosis in obstructive sleep apnea: a link to endothelial dysfunction. Am J Respir Crit Care Med 175:1186–1191

    Article  PubMed  Google Scholar 

  36. Nieto FJ, Herrington DM, Redline S, Benjamin EJ, Robbins JA (2004) Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 169:354–360

    Article  PubMed  Google Scholar 

  37. Smith SC Jr, Milani RV, Arnett DK et al (2004) Atherosclerotic vascular disease conference: writing group II: risk factors. Circulation 109:2613–2616

    Article  PubMed  Google Scholar 

  38. Vlachopoulos C, Aznaouridis K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 55:1318–1327

    Article  PubMed  Google Scholar 

  39. Seetho IW, Parker RJ, Craig S, Duffy N, Hardy KJ, Wilding JP (2014) Obstructive sleep apnea is associated with increased arterial stiffness in severe obesity. J Sleep Res 23(6):700–708

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We gratefully acknowledge the help of Karin Springmann for her excellent technical support and Sonotechnik Austria for providing us with the AngE Pro8®.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Skowasch.

Additional information

C. A. Schaefer, L. Adam, C. Pizarro, and D. Skowasch contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schaefer, C.A., Adam, L., Weisser-Thomas, J. et al. High prevalence of peripheral arterial disease in patients with obstructive sleep apnoea. Clin Res Cardiol 104, 719–726 (2015). https://doi.org/10.1007/s00392-015-0834-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-015-0834-3

Keywords

Navigation